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Summary 
Studies were performed to investigate the effect of diets rich in oleic or linoleic acids on the activity of 
plasma cholesteryl ester transfer protein (CETP) in normolipidemic subjects. Previous to the test diets, all 
subjects consumed a baseline diet rich in saturated fatty acids (“sat-diet”) for 17 days. The test diets, rich 
in either monounsaturated fatty acids (“mono-diet”) or rich in polyunsaturated fatty acids (“poly-diet”), 
were given for 5 weeks to 52 normolipidemic healthy volunteers. The activity of CETP was measured, 
using a method independent of endogenous plasma lipoproteins, as the rate of exchange of radioactive 
cholesteryl oleate between labelled LDL and unlabelled HDL. The “mono-diet” induced a statistically 
significant decrease in CETP activity (from 115 + 20 to 102 k 19 units/ml plasma, P < 0.01) while the 
small decrease on the “poly-diet” (from 111 f 23 to 107 f 22 units/ml plasma) did not reach significancy. 
The percentual decrease in CETP activity induced by the “mono-diet” was higher than that induced by the 
“ poly-diet” as was also found for the decrease in LDL cholesterol. In both diet groups a positive 
correlation was found between changes in CETP activity and changes in plasma total or (VLDL + LDL) 
cholesterol. The results suggest that high levels of dietary monounsaturated fatty acids may result in 
decreased plasma CETP activity, as well as LDL cholesterol levels. The mechanisms of these effects, and 
their possible interrelations, remain to be established. 
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Introduction 
Correspondence to: Dr. J.E.M. Groener, Dept. of Biochem- 
istry I, Erasmus University Rotterdam, P.O. Box 1738, 3000 
DR Rotterdam, The Netherlands. Tel.: 0104087321; Fax: 
01 O-4362841. 
Human plasma contains a lipid transfer protein 
(CETP) which catalyses the transfer of cholesteryl 
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esters (CE), triglycerides (TG) and phospholipids 
between lipoproteins [l-6]. This process of lipid 
transfer leads to major alterations in the composi- 
tion of lipoproteins and therefore affects lipopro- 
tein metabolism. Although the function of CETP 
has been partially identified, little is known about 
the regulation of CETP activity in human plasma. 
It has been reported that the activity of CETP is 
increased in hypercholesterolemic [7] and dysbe- 
talipoproteinemic subjects [8]. In hyperlipidemic 
subjects fed a high-fat or low-fat diet the activity 
of CETP changed in parallel with the concentra- 
tion of (VLDL + LDL) cholesterol [9]. Animal 
studies with rabbits, a species with a high CETP 
activity, showed that elevations in the activity of 
CETP go together with elevations in plasma total 
cholesterol and (VLDL + LDL) cholesterol, both 
in diet-induced hypercholesterolemia and in hy- 
percholesterolemia caused by a genetic defect in 
the LDL receptor [lO,ll]. In hyper- and hypo-re- 
sponding rabbits, diet-induced hypercholestero- 
lemia coincides with increases in CETP activity 
[12]. A similar diet-induced effect on CETP has 
been reported in the hamster, although the plasma 
CETP activity in this species is much lower than 
in man and rabbit [13]. All these studies deal with 
hyperlipidemic situations. 
In this report we focus on the effect of diets 
rich in monounsaturated fatty acids (“mono-diet”) 
or rich in polyunsaturated fatty acids (“poly-diet”) 
on the activity of plasma CETP. The activity of 
CETP was determined independent of the lipopro- 
teins present in the plasma sample to be measured 
and was measured as exchange of CE between 
exogenous LDL and exogenous HDL. The mea- 
sured activity is the result of the presence of 
CETP and the putative CETP-inhibitor [6,14,15]. 
It is the first report on diet-induced alteration 
in plasma CETP activity in normolipidemic sub- 
jects. 
Methods 
Subjects and diet 
This study was approved by the Ethical Com- 
mittee of the Department of Human Nutrition, 
Agricultural University, Wageningen. Detailed in- 
formation on the characteristics of the subjects, 
the diets, and the study protocol is presented 
elsewhere in a paper that describes the effects of 
the 2 diets on lipoprotein levels [16]. 
Fifty-two normolipidemic subjects, 22 men (age 
20-48 years) and 30 women (age 19-45 years) 
volunteered in the study. The diets used differed 
only in the fatty acid composition. All subjects 
initially received a diet containing 19.3 energy % 
(en%) saturated fatty acids, 11.5 en% monoun- 
saturated fatty acids, and 4.6 en% polyunsaturated 
fatty acids for 17 days (baseline period). After this 
period subjects received a diet rich in either 
mono-unsaturated fatty acids (“mono-diet”: 12.9 
en% saturated fatty acids, 15.1 en% monoun- 
saturated fatty acids and 7.9 en% polyunsaturated 
fatty acids) or in polyunsaturated fatty aicds 
(“poly-diet”: 12.6 en% 
en% monounsaturated 
polyunsaturated fatty 
period). 
Sample collection 
Blood was collected 
saturated fatty acids, 10.8 
fatty acids and 12.7 en% 
acids) for 36 days (test 
after an overnight fast on 
day 14 and 17 (baseline period), and on day 50 
and 53 (test period) in tubes containing EDTA 
(1.5 mg/ml) and placed on ice. Plasma was sep- 
arated within 1 h and the plasma samples used for 
the measurement of CETP activity were frozen 
within 4 h. Samples were kept at -20” C and 
analyzed within 5 months. All samples were 
analyzed separately and the means of the 2 sam- 
ples of day 14 and 17 and of day 50 and 53 were 
used as the actual values. On the same days blood 
was sampled and serum was prepared for the 
measurement of serum lipids [16]. 
Measurement of CETP activity 
The activity of CETP in plasma was de- 
termined exactly as described by Groener et al. 
[17], using an isotope assay detecting the exchange 
of radioactive CE between [r4C]cholesteryl oleate 
labelled LDL and unlabelled HDL. The measured 
activity, CETP activity, is independent of endoge- 
nous lipoproteins. Plasma samples were treated 
with polyethylene glycol to precipitate VLDL + 
LDL and the activity of CETP was measured in 
the (VLDL + LDL)-free plasma. In, plasma of 
normal fasting subjects CETP is mostly present on 
HDL, and VHDL and very small amounts are 
found in the lipoprotein-free fraction [1,18,19]. 
Recently this localization of CETP in plasma was 
confirmed, using a radioimmuno assay for CETP 
[20]. The amount of HDL introduced with the 
(VLDL + LDL)-free supernatant to the assay sys- 
tem was less than 15% of the total amount of 
HDL present in the assay medium and does not 
affect the measurement. LDL and HDL, used for 
the measurement of CETP, were isolated from one 
batch of freshly isolated human plasma by re- 
peated ultracentrifugation from densities 1.006 < 
d < 1.063 g/ml and 1.063 < d < 1.21 g/ml, re- 
spectively [21]. LDL was labelled with [t4C]choles- 
teryl oleate using the vesicle method described by 
Morton & Zilversmit [6]. All plasma samples were 
assayed in one week. Plasma samples from one 
subject were analyzed on one day. The within run 
variation was 2.7%. The differences in the CETP 
activity in the 2 samples from one subject taken at 
day 14 and 17 or at day 50 and 53 were 6.3 k 4.9%. 
This difference was calculated relative to the value 
on day 14 and day 50 respectively. Standard sera 
were used to control the day to day variation in 
the experiment. The day to day variation in this 
set of experiments was 7.7%. The activity of CETP 
can be calculated as nmoles cholesteryl esters ex- 
changed/h/ml plasma [17]. Since the actual value 
of the CETP activity depends on the batches of 
labelled LDL and unlabelled HDL used, the activ- 
ity of CETP is expressed in arbitrary units 
(units/ml plasma). 
Other methods 
Free cholesterol and total cholesterol in iso- 
lated lipoproteins were measured enzymatically 
TABLE 1 
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with kit nr. 310328 (Boehringer Mannheim). 
Cholesteryl ester was calculated as the difference 
in total cholesterol and free cholesterol. 
Data analysis 
Statistical analyses are based on the entire sam- 
ple of each diet group. Descriptive statistics, mean 
and standard deviation, are given separately for 
men and women. The paired Student t-test was 
used to determine significant differences between 
test and control samples. Student’s t-test was used 
to analyze differences in changes due to the 2 test 
diets. Pearson correlation coefficients were used to 
measure the association between alterations in 
CETP and alterations in other lipid parameters. 
Relationships between CETP activity and lipid 
parameters, Quetelet index and age were esti- 
mated using Pearson correlation coefficient (r ) 
and Spearman correlation coefficient (cc), as ap- 
propriate. 
Results 
CETP activity was normally distributed (both 
in men and women) while on the baseline high- 
saturated fat diet. It ranged from 68.1 to 154.9 
units/ml plasma, with a mean of 113 k 22 
units/ml. No difference was found between CETP 
activities in men and women. 
Table 1 presents the CETP activity in plasma 
of all subjects at the end of the baseline and at the 
end of the test period. Subjects were divided into 
men and women, but statistical analyses were also 
EFFECT OF “MONO-DIET” AND “POLY-DIET” ON CETP ACTIVITY (UNITS/ml PLASMA) 
Men Women All 
“ mono-diet” “poly-diet” “mono-diet” “poly-diet” “mono-diet” “poly-diet” 
Baseline 114+17 117*19 116rt24 107 + 26 115 *20 111 523 
Test 99*16* 111+15 104*21* 104 + 26 102 *19** 107 *22 
Percent change - 10.2 * 10.4 -3.1 *11.9 
95% confidence level -14.3 to -1.g+ 
Values are mean + S.D. Significant differences between the values in the baseline period and the test period by paired Student r-test: 
* P (0.01; **P<o.ctol. +denotes a significant difference in changes between diet groups (P < 0.05). Baseline values were 
measured after 14 and 17 days on a baseline diet rich in saturated fatty acids (“sat-diet”). Test values were measured on day 50 and 
53 of the experiment, i.e. after 33 and 36 days on diets either rich in monounsaturated fatty acids (“mono-diet”) or rich in 
polyunsaturated fatty acids (” poly-diet”). 
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performed on the whole diet group. No difference 
in CETP activity was found between the baseline 
samples of the 2 diet groups or between men and 
women. The data show a significant decrease in 
CETP activity in the “mono-diet” group, in both 
men and women. The small decrease in CETP 
activity in the “poly-diet” group was not statisti- 
cally significant. It cannot be excluded completely 
that these decreases in CETP activity are simply 
caused by the time period between the baseline 
and test samples. Therefore the effects of the 2 
diets were compared directly. CETP activity falls 
by 10.2 + 10.4% on the “mono-diet” and by 3.1 f 
11.9% on the “ poly-diet” (95% confidence interval 
of the difference in percentual change between the 
2 diets groups: -14.3% to -1.8%). 
Table 2 shows a summary of the measured lipid 
parameters, in so far as they are of importance for 
the interpretation of the present data. More de- 
tailed information on the effects of the diets on 
the different lipoprotein parameters has been pre- 
sented elsewhere [16]. 
Responses of CETP activity and lipid levels to 
the two different diets were compared and Pear- 
son correlation coefficients were calculated. In 
both diet groups changes in CETP activity corre- 
lated positively with changes in (VLDL + LDL) 
cholesterol (“mono-diet”: r = 0.471, P = 0.02; 
“ poly-diet”: r = 0.509, P = O.Ol), total cholesterol 
(“mono-diet”: r = 0.366, P = 0.07; “poly-diet”: 
r = 0.525, P = O.Ol), LDL-cholesterol (“mono- 
diet”: r = 0.390, P = 0.05; “poly-diet”: r = 0.508, 
P = O.Ol), but not with HDL-cholesterol. Analyz- 
ing alterations in CETP activity and alterations in 
plasma lipid values introduced by the 2 diets 
together revealed significant positive correlations 
between changes in CETP activity and changes in 
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Fig. 1. Relationship between CETP-response and (VLDL+ 
LDL) response in the “mono-diet” group (r = 0.471, P = 0.02) 
and the “poly-diet” group (r = 0.509, P = 0.01). Response is 
defined as the difference between the test period and the 
baseline period. Pearson correlation coefficient (r) for all 
subjects is 0.523 (P = 0.0001). 0, “mono-diet”; 0, “poly-diet”. 
(VLDL + LDL) cholesterol (r = 0.523, P = 
O.OOOl), total cholesterol (r = 0.492, P = 0.0002) 
and LDL-cholesterol (r = 0.497, P = 0.0002), but 
not with changes in HDL-cholesterol. Fig. 1 pre- 
sents the data for the relationship between changes 
in CETP activity and changes in (VLDL + LDL) 
cholesterol. 
The baseline samples obtained in this study 
reflect the CETP activity and lipoprotein levels on 
a “Western” type diet and were used to determine 
the relationship between CETP activity and age, 
Quetelet index and lipoprotein levels. Positive cor- 
relations were found between CETP activity and 
(VLDL + LDL) cholesterol (r = 0.285, P = 0.04) 
TABLE 2 
EFFECTS OF THE “MONO-DIET” AND “POLY-DIET”’ ON SERUM LIPID LEVELS (IN mM) 
Diet 
“Mono-diet” (n = 25) group 
“ Poly-diet” (n 27) group = 
Baseline 
Total chol. 
5.19 f 0.93 
5.09*0.71 
HDL-chol. TG 
1.35 *0.31 1.01*0.46 
1.41 f 0.34 0.87 *0.34 
Test 
Total chol. 
4.54 f 0.89 * 
4.65 * 0.12 * 
HDL-chol. TG 
1.30 rt 0.32 0.98 f 0.44 
1.39 rfr 0.38 0.82 kO.39 
Values are meanf S.D. Baseline values refer to the baseline diet (“sat-diet”), test values refer to the “mono-diet” or “poly-diet”. 
Significant differences by paired Student’s f-test: * P < 0.001. For further information see legend of Table 1. 
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and LDL cholesterol (r = 0.289, P = 0.04) and 
negative correlation was found between CETP 
activity and HDL-cholesterol (r = - 0.304, P = 
0.03). No significant correlations (rs) were found 
between CETP activity and age or Quetelet index. 
Discussion 
This study reports a decrease in the activity of 
CETP in normolipidemic subjects, consuming a 
diet enriched in monounsaturated fatty acids. The 
consumption of a diet enriched in polyunsaturated 
fatty acids resulted in a smaller (not significant) 
decrease. In both diet groups positive correlations 
were found between changes in CETP activity and 
changes in (VLDL + LDL) cholesterol, LDL 
cholesterol and total cholesterol. The results sug- 
gest that high levels of dietary monounsaturated 
fatty acids may specifically result in relatively low 
plasma CETP levels. The mechanism of this puta- 
tive regulatory effect remains to be established. 
Alterations in the activity of CETP have been 
reported before in a diet study with hyperlipi- 
demic subjects [9], where the changes in CETP 
activity coincided with changes in (VLDL + LDL) 
cholesterol. Animal studies have shown an in- 
crease in CETP activity parallel to an increase in 
plasma cholesterol under various conditions 
[1,0,11,13]. The latter studies deal with pronounced 
changes in the level of plasma cholesterol. The 
interesting feature of the present study is that 
natural mixed solid diets differing in unsaturated 
fatty acids, but not in saturated fatty acids or total 
fat, were used. It is interesting that the decrease in 
CETP activity on the “mono-diet”, relative to the 
“ poly-diet”, parallels the decrease in plasma total, 
(VLDL + LDL), and LDL cholesterol. A high ac- 
tivity of CETP has been reported in hypercholes- 
terolemic, dysbetalipoproteinemic and diabetic 
subjects [7,8,22], suggesting that high CETP activ- 
ity coincides with high plasma (VLDL + LDL) 
cholesterol. At present it is impossible to assess 
whether the correlation of changes in CETP activ- 
ity with changes in (VLDL + LDL) cholesterol 
points to a causal relationship. Since various situa- 
tions of hypercholesterolemia all coincide with an 
increase in CETP activity, it may be that CETP 
activity is regulated by the level of (VLDL + LDL) 
cholesterol. This phenomenon has been thor- 
oughly discussed for rabbits [lO,ll], but no un- 
derlying mechanism could be given. Recently 
Quintet et al. [23] reported that in cholesterol-fed 
rabbits the increased activity of CETP coincides 
with increased mass of CETP in plasma and in- 
creased mRNA levels in the liver, suggesting that 
increased hepatic synthesis of CETP is involved in 
this diet-induced change in plasma CETP in the 
rabbit. In rabbit CETP mRNA is only found in 
the liver, in contrast to the wide spread tissue 
distribution of CETP mRNA in man [23-251. 
Human HepG2 cells, human monocyte-derived 
macrophages, and CaCo-2 cells derived from hu- 
man enterocyte epithelium all synthesize and 
secrete CETP [26-291. The secretion of CETP by 
the macrophages and the CaCo-2 cells is regu- 
lated. Cholesterol loading of the macrophages re- 
sults in an increase in the secretion of CETP 
activity. This suggests that the secretion of CETP 
by macrophages may be under the influence of 
plasma (VLDL + LDL) cholesterol levels. Ad- 
ditional experiments are needed to clarify the reg- 
ulation of CETP synthesis in man. 
The baseline samples obtained in this study 
were used to determine possible relationships be- 
tween plasma levels of CETP activity and certain 
population and lipoprotein parameters. In agree- 
ment with an earlier study [7] there were positive 
correlations between CETP activity and (VLDL + 
LDL) cholesterol, as well as with plasma total 
cholesterol, and a negative correlation with HDL 
cholesterol. Significant correlations between CETP 
activity and age or Quetelet Index on CETP activ- 
ity were not observed. 
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